Haemonetics Corp (HAE)
95.73
+0.93
(+0.98%)
USD |
NYSE |
May 17, 16:00
95.76
+0.02
(+0.03%)
After-Hours: 20:00
Haemonetics Cash from Operations (Annual): 181.75M for March 31, 2024
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
Date | Value |
---|---|
March 31, 2024 | 181.75M |
March 31, 2023 | 273.06M |
March 31, 2022 | 172.26M |
March 31, 2021 | 108.80M |
March 31, 2020 | 158.22M |
March 31, 2019 | 159.28M |
March 31, 2018 | 220.35M |
March 31, 2017 | 159.74M |
March 31, 2016 | 121.86M |
March 31, 2015 | 127.18M |
March 31, 2014 | 139.52M |
March 31, 2013 | 85.07M |
March 31, 2012 | 115.32M |
March 31, 2011 | 123.46M |
March 31, 2010 | 130.67M |
March 31, 2009 | 116.36M |
March 31, 2008 | 77.67M |
Date | Value |
---|---|
March 31, 2007 | 83.56M |
March 31, 2006 | 85.62M |
March 31, 2005 | 71.21M |
March 31, 2004 | 76.77M |
March 31, 2003 | 46.98M |
March 31, 2002 | 33.31M |
March 31, 2001 | 56.82M |
March 31, 2000 | 53.46M |
March 31, 1999 | 33.71M |
March 31, 1998 | 20.40M |
March 31, 1997 | 46.90M |
March 31, 1996 | 54.80M |
March 31, 1995 | 15.60M |
March 31, 1994 | 27.00M |
March 31, 1993 | 35.90M |
March 31, 1992 | 18.80M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Annual) Range, Past 5 Years
108.80M
Minimum
2021
273.06M
Maximum
2023
178.82M
Average
172.26M
Median
2022
Cash from Operations (Annual) Benchmarks
ResMed Inc | 693.30M |
Stryker Corp | 3.711B |
Masimo Corp | 94.10M |
Insulet Corp | 145.70M |
InfuSystems Holdings Inc | 11.22M |